SeraNovo BV (Leiden, The Netherlands) is pleased to announce the closing of a License Agreement with Équilibre BioPharmaceuticals Corporation (New York, USA), a biopharmaceutical company engaged in the research and development of small molecules in
WAGENINGEN - Diagnostic startup company Scope Biosciences B.V. has raised €1 Million funding from Utrecht based GenDx, specialized in Next Generation Sequencing (NGS) products for transplant diagnostics.
Mercurna has reached its scientific and IP milestones of the RedMedtech Discovery Fund II (RMDFII) by providing exciting data (in vitro and in vivo) on mCura1, Mercurna’s lead formulation for chronic kidney disease.
ShanX Medtech is delighted to have been named one of Hello Tomorrow’s Deep Tech Pioneers! Being a Deep Tech Pioneer means that they have been recognised by Hello Tomorrow as 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘮𝘰𝘴𝘵 𝘱𝘳𝘰𝘮𝘪𝘴𝘪𝘯𝘨 𝘱𝘳𝘰𝘫𝘦𝘤𝘵𝘴 𝘪𝘯 𝘥𝘦𝘦𝘱 𝘵𝘦𝘤𝘩 𝘵𝘰 𝘥𝘢𝘵𝘦.
Last week, the Venture Challenge Fall 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.